Exciva raised €51M in a Series B round in Jan 2026. The company is based in Heidelberg, Germany. Investors in the round: Carma Fund, Andera Partners, EQT Life Sciences and 5 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €51M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
